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Glutamate is converted to ornithine. Many enzyme reac-
tions are involved in the inter-conversion of glutamate
and ornithine by intestinal mucosa [1]. The modulation
of the conversion might be a target in the final modula-
tion of glutamatergic transmission. Since ornithine
synthesis depends on glutamate, a larger amount of
ornithine can explicate a feedback limiting effect on glu-
tamatergic availability. A possible limited glutamatergic
availability is here compared with a dopaminergic acti-
vation obtained by means of amantadine. In fact, both
limited glutamatergic action and increased dopaminergic
activity have been indicated to be crucial in analgesia
determined at the level of anterior cingulate cortex
(ACC) [2]. Experiences in chronic Migraine (M) therapy:
in 107 chronic M sufferers (69 females, 38 males, mean
age 33.8 + 4.1 SD) ornithine (500 mg twice a day for
3 months) induced an amelioration paralleling the
amantadine induced-relief (100 mg amantadine/day for
3 months). Indeed, both the active compounds induced
a decrease of the attacks of 40% p>0.001 versus 30-days
wash-out and 30-days run-in periods A 14-days treat-
ment induced a decrease (p>0.0001) of visceral/vascular
hyperalgesia/allodynia rating -65% in a 0-10 VAS when
comparing baseline values with the ones after both
amantadine and ornithine administered in the aforemen-
tioned doses. These results suggest: a) that ornithine
may act in the inteconversion of glutamate in all the tis-
sues. Moreover, large doses of ornithine may induce a
negative feedback in the mentioned interconversion. b)
Dopaminergic and glutamatergic transmission, having
opposite activity in pain processing in the ACC, that,
in is turn, seems to have a crucial structure in pain
dyshomeosthasis, seemingly act on the central mechan-
isms of chronic M.
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